FibroGenesis entre as Top 20 Empresas Mais Inovadoras de 2020, em 2º lugar na Lista da Global Smart Leaders Magazine
08 oct. 2020 13h59 HE
|
FibroGenesis
HOUSTON, Oct. 08, 2020 (GLOBE NEWSWIRE) -- A FibroGenesis, principal desenvolvedora de soluções terapêuticas com base em fibroblastos para necessidades médicas não atendidas, tem o orgulho de...
FibroGenesis、Global Smart Leaders誌の2020年最も革新的な企業トップ20で第2位に選出
08 oct. 2020 13h59 HE
|
FibroGenesis
ヒューストン発, Oct. 09, 2020 (GLOBE NEWSWIRE) -- 満たされていない医療ニーズに応える線維芽細胞ベースの治療ソリューションの大手開発企業FibroGenesisは、Global Smart Leaders誌の2020年最も革新的な企業 (Most Innovative Companies of 2020)...
FibroGenesis Named Top 20 Most Innovative Companies of 2020 and Lands at the #2 Spot on Global Smart Leaders Magazine List
08 oct. 2020 10h07 HE
|
FibroGenesis
HOUSTON, Oct. 08, 2020 (GLOBE NEWSWIRE) -- FibroGenesis, the leading developer of fibroblast based therapeutic solutions for unmet medical needs, is proud to announce Global Smart Leaders Magazine...
A FibroGenesis apresenta um avanço na prevenção da coagulação sanguínea em decorrência da COVID-19
13 août 2020 00h32 HE
|
FibroGenesis
HOUSTON, Aug. 13, 2020 (GLOBE NEWSWIRE) -- A FibroGenesis, uma empresa de estudos clínicos que desenvolve soluções terapêuticas baseadas em fibroblastos voltadas para necessidades médicas não...
FibroGenesis、COVID-19による血液凝固を予防する画期的成果を報告
13 août 2020 00h32 HE
|
FibroGenesis
ヒューストン発, Aug. 13, 2020 (GLOBE NEWSWIRE) -- 線維芽細胞ベースの治療ソリューションの開発により、満たされていない医療ニーズに応える臨床開発企業FibroGenesisは本日、COVID-19治療へのPneumoBlast™製品の使用を後押しする新たなデータを発表した。...
FibroGenesis informa avances en la prevención de coágulos sanguíneos por el COVID-19
13 août 2020 00h32 HE
|
FibroGenesis
HOUSTON, Aug. 12, 2020 (GLOBE NEWSWIRE) -- FibroGenesis, una empresa de etapa clínica que desarrolla soluciones terapéuticas basadas en fibroblastos para cubrir necesidades médicas sin tratamiento,...
FibroGenesis fait état d'une avancée dans la prévention de la coagulation sanguine liée au COVID-19
13 août 2020 00h32 HE
|
FibroGenesis
HOUSTON, 13 août 2020 (GLOBE NEWSWIRE) -- FibroGenesis, une société de stade clinique qui développe des solutions thérapeutiques à base de fibroblaste pour les besoins médicaux non satisfaits,...
FibroGenesis meldet Durchbruch bei der Prävention von Blutgerinnung bei COVID-19
13 août 2020 00h32 HE
|
FibroGenesis
HOUSTON, Texas (USA), Aug. 13, 2020 (GLOBE NEWSWIRE) -- FibroGenesis, ein Unternehmen im Bereich der klinischen Forschung, das therapeutische Lösungen auf Fibroblastenbasis für ungedeckte...
FibroGenesis Reports Breakthrough in Prevention of COVID-19 Blood Clotting
12 août 2020 10h07 HE
|
FibroGenesis
HOUSTON, Aug. 12, 2020 (GLOBE NEWSWIRE) -- FibroGenesis, a clinical stage company developing fibroblast based therapeutic solutions for unmet medical needs, announced today new data supporting...